|
|
|
To stab or to swallow? For treating conditions in the I&I (immunology and inflammation) space – think psoriasis, as one common example – some see the holy grail of delivery as moving from injectable to oral administration. In this inaugural episode of Sit and Deliver, host Tom von Gunden invites Dinesh Patel, president and CEO at clinical stage biotech company Protagonist Therapeutics, to deliver the rationale for targeting I&I diseases and other therapeutic areas with oral peptides. |
|
|
|
|
|
|
| Placing Patients At The Center Of Drug Design | Q&A | Catalent | Experts discuss the best time to start thinking about patient-centricity, the steps developers can take to achieve patient-centric drug design, and how formulation and dosage forms can make a difference. |
|
|
|
|
|
|
| The premier event on pre-filled syringes and injection devices brings together key field players to discuss the breakthroughs that are propelling the industry forward. A comprehensive agenda covers critical topics, including sustainability, large-volume injections, digital health, and regulatory compliance. Additionally, the exhibit hall featuring 120+ exhibitors, poster presentations, lightning sessions, lively Q&As, networking activities, and Drug Delivery Innovation Awards make this event a must-attend. Register now |
|
|
|
|
|
|
.png){kind=logo}
